Matrixx Projects Profit, But Zicam Litigation "Storm Clouds" Could Still Rain

Matrixx Initiatives believes it has emerged with a plan for returning to growth and profitability after navigating the gauntlet of an FDA warning, product recall and millions in lost revenue in fiscal 2010